A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew B Lassman, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital (pmh)
Toronto, Ontario, Canada
- University of Alabama
Birmingham, Alabama, United States
- University of Southern California (usc Norris Comprehensive Cancer Center and Lac+usc Medical Center)
Los Angeles, California, United States
- University of California
San Francisco, California, United States
- Baptist Hospital of Miami Cancer Institute, 8900 North Kendall Drive
Miami, Florida, United States
- Piedmont Healthcare
Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Hackensack Meridian Health, 92 Second Street
Hackensack, New Jersey, United States
- Atlantic Health Systems Hospital Corp.
Morristown, New Jersey, United States
- Northwell Health
Lake Success, New York, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Lenox Hill Hospital-Northwell Health
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Utah - Huntsman Cancer Institute
Salt Lake City, Utah, United States
- University of Washington - Alvord Brain Tumor Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2020
- Primary completion
- 3 Jul 2023
- Completion
- 3 Jul 2023
- Last update posted
- 16 Dec 2024
- Registered enrollment
- 74
- Registry id
- NCT04421378
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.